Read More: eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
eGenesis Presents New Data on Long-Term Survival in Preclinical Kidney Xenotransplantation at American Transplant Congress 2023
Karius and eGenesis partner to help accelerate xenotransplantation for patients in need of organ transplants
eGenesis Announces Knut Niss as Chief Technology Officer
eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer
eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer
eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model
eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors
eGenesis Expands Research Collaboration with Leading Academic Medical Center
eGenesis Appoints Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer